3D printing specialist Microlight3D and deep-tech company Eden Tech are collaborating to advance the development of microfluidic equipment for healthcare researchers and developers.

Under the team-up, the French companies will combine Microlight3D’s Smart Print UV lithograph for producing 2D shapes at micron resolution with Eden Tech’s FLUI’DEVICE platform for developing microfluidic devices. The combined technologies are expected to help researchers more rapidly create prototypes for microfluidic equipment such as moulds, devices, and structures.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

According to the companies, their combined technologies will support healthcare researchers in creating complex designs with the “unmatched accuracy required” in the development of microfluidics used in diagnostic tools, lab-on-a-chip devices, and research apparatus.

Eden Tech sales head Victor Morel commented: “We believe that this partnership will set a new benchmark in the field of microfluidics.

“With healthcare systems and research laboratories increasingly seeking efficient and reliable microfluidic devices, the demand for solutions that integrate precision, scalability and cost-effectiveness has never been greater.”

The combined technology provisions are also expected to result in faster and more efficient workflows compared to computer-aided design (CAD) printing software. In addition, the ability to export microfluidic designs created with the combined technologies into various formats to ensure compatibility with production systems is expected to cut down on manufacturing errors.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Microlight3D founder Denis Barbier said the partnership allows the company to offer a solution for creating microfluidic designs compatible with the formats used by its machines.

“This will enable our users to integrate this tool into their current workflow, while streamlining the steps involved,” said Barbier.

Elsewhere in the field of microfluidics, Parallel Fluidics secured $7m in seed funding last year to develop a custom manufacturing platform for microfluidic devices.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact